Lithium is safe and tolerable as maintenance therapy for up to 28 weeks for children and teens with bipolar disorder (BD), new research suggests. A randomized, double-blind study showed that ...

For many people who have bipolar I, lithium is that most elusive of pharmacological treatments, the “magic bullet”—a single intervention that completely eliminates the symptoms of a disease. Since the ...

This is the fifth post in a series on non-pharmacologic treatments of bipolar disorder. Previous posts briefly reviewed the evidence for amino acids, the B vitamin choline, and a proprietary nutrient ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Lithium was associated with a higher risk of thyroid and kidney ...

The interview highlights that bipolar disorder manifests in multiple distinct subtypes, which may be due to genetic differences that contribute to varied responses towards lithium medication.

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

A diagnostic distinction for postpartum psychosis in the DSM will improve detection, treatment, and prevention, an expert ...

ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...

Please provide your email address to receive an email when new articles are posted on . AL001 by Alzamend Neuro will undergo a phase 2a trial in patients with major depressive disorder. The ...

Compared with lithium, valproate, olanzapine, quetiapine, and risperidone generally exhibited a lower likelihood of thyroid dysfunction. HealthDay News — Lithium is associated with an increased risk ...

Higher lithium serum levels linked to elevated rates of hypothyroidism, hyperthyroidism, and CKD3+. (HealthDay News) — Lithium is associated with an increased risk for thyroid dysfunction and chronic ...